Galmed Pharmaceuticals (GLMD) Institutional Ownership $1.81 0.00 (0.00%) As of 10:25 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Galmed Pharmaceuticals (NASDAQ:GLMD)CurrentInstitutional OwnershipPercentage76.14%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$81.03KNumber ofInstitutional Sellers(last 12 months)0 Get GLMD Insider Trade Alerts Want to know when executives and insiders are buying or selling Galmed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLMD Institutional Buying and Selling by Quarter Galmed Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2025Schonfeld Strategic Advisors LLC25,400$81K0.0%N/A3.969% 5/7/2024CVI Holdings LLC74,665$25K0.0%-72.3%1.479% 8/15/2023BVF Inc. IL89,853$261K0.0%-93.3%5.348% 5/16/2023BVF Inc. IL1,347,755$575K0.0%-22.5%5.348% 7/18/2022Western Wealth Management LLC59,074$38K0.0%N/A0.235% 2/8/2022Raymond James & Associates203,540$370K0.0%-11.4%0.811% 2/7/2022Ibex Investors LLC874,144$1.59M0.5%-26.7%3.485% 11/16/2021Squarepoint Ops LLC25,404$71K0.0%-22.2%0.101% 11/16/2021Toroso Investments LLC24,657$69K0.0%N/A0.098% 11/5/2021Ibex Investors LLC1,193,100$3.33M0.7%-2.3%4.756% 11/2/2021Raymond James Financial Services Advisors Inc.21,304$59K0.0%+27.2%0.085% 11/2/2021Raymond James & Associates229,640$641K0.0%+10.5%0.915% 8/16/2021Squarepoint Ops LLC32,634$99K0.0%-40.5%0.130% 8/16/2021Nantahala Capital Management LLC944,631$2.87M0.1%-22.2%3.766% 8/16/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.867% 8/5/2021Ibex Investors LLC1,220,794$3.71M1.3%-19.9%4.868% 7/31/2021Brave Asset Management Inc.11,470$35K0.0%N/A0.046% 5/19/2021Squarepoint Ops LLC54,884$188K0.0%+161.2%0.219% 5/17/2021Goldman Sachs Group Inc.26,419$91K0.0%N/A0.105% 5/14/2021Nantahala Capital Management LLC1,213,540$4.16M0.1%-37.0%4.838% 5/13/2021Renaissance Technologies LLC60,700$208K0.0%-47.6%0.242% (Data available from 1/1/2016 forward) GLMD Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLMD shares? During the previous two years, the following institutional investors and hedge funds held shares of Galmed Pharmaceuticals shares: BVF Inc. IL ($261K), and Schonfeld Strategic Advisors LLC ($81K), CVI Holdings LLC ($25K).Learn more on Galmed Pharmaceuticals' institutional investors. What percentage of Galmed Pharmaceuticals' stock is owned by institutional investors? 76.14% of Galmed Pharmaceuticals' stock is owned by institutional investors. Learn more on GLMD's institutional investor holdings. Which institutional investors have been buying Galmed Pharmaceuticals' stock? The following institutional investors have purchased Galmed Pharmaceuticals' stock in the last 24 months: Schonfeld Strategic Advisors LLC ($25.40K). How much institutional buying is happening at Galmed Pharmaceuticals? Institutional investors have bought a total of 25,400 shares in the last 24 months. This purchase volume represents approximately $81.03K in transactions. Related Companies EYEN Institutional Ownership ALVR Institutional Ownership ATHA Institutional Ownership IBIO Institutional Ownership EQ Institutional Ownership CTXR Institutional Ownership BGXX Institutional Ownership PHIO Institutional Ownership BCDA Institutional Ownership TRIB Institutional Ownership This page (NASDAQ:GLMD) was last updated on 7/3/2025 by MarketBeat.com Staff From Our PartnersThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredA grave, grave error.Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...Porter & Company | SponsoredThis Crypto Is Set to Explode in JanuaryFree summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...Crypto 101 Media | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galmed Pharmaceuticals Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galmed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.